AU1827299A - Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal - Google Patents

Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal

Info

Publication number
AU1827299A
AU1827299A AU18272/99A AU1827299A AU1827299A AU 1827299 A AU1827299 A AU 1827299A AU 18272/99 A AU18272/99 A AU 18272/99A AU 1827299 A AU1827299 A AU 1827299A AU 1827299 A AU1827299 A AU 1827299A
Authority
AU
Australia
Prior art keywords
f2alpha
prostaglandin
combination
sexual arousal
treating impotence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18272/99A
Inventor
Nathan Earl Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/992,946 external-priority patent/US5981593A/en
Priority claimed from US09/038,378 external-priority patent/US5962528A/en
Application filed by Individual filed Critical Individual
Publication of AU1827299A publication Critical patent/AU1827299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU18272/99A 1997-12-18 1998-12-15 Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal Abandoned AU1827299A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US08/992946 1997-12-18
US08/992,946 US5981593A (en) 1991-07-03 1997-12-18 Prostaglandin E2 treatment of impotence
US508798A 1998-01-09 1998-01-09
US09/005087 1998-01-09
US09/038378 1998-03-11
US09/038,378 US5962528A (en) 1991-07-03 1998-03-11 Prostaglandin E2 /F2α combination for treating impotence
PCT/US1998/026609 WO1999030718A2 (en) 1997-12-18 1998-12-15 PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL

Publications (1)

Publication Number Publication Date
AU1827299A true AU1827299A (en) 1999-07-05

Family

ID=27357802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18272/99A Abandoned AU1827299A (en) 1997-12-18 1998-12-15 Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal

Country Status (5)

Country Link
EP (1) EP1059926A2 (en)
CN (1) CN1282249A (en)
AU (1) AU1827299A (en)
CA (1) CA2314369A1 (en)
WO (1) WO1999030718A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
WO2000053148A2 (en) * 1999-03-08 2000-09-14 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
IL139456A0 (en) * 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
CA2408417C (en) * 2000-05-12 2009-09-15 Novalar Pharmaceuticals, Inc. Local anesthetic methods and kits
SE0100158D0 (en) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere's disease and tinnitus
US8926572B2 (en) * 2008-10-10 2015-01-06 Peter Forsell Stimulation of sexually responsive tissue of the vulva
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917864A (en) * 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
US4005221A (en) * 1974-04-01 1977-01-25 Karim Sultanali M M Use of prostaglandins to induce menstruation
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
SE463851B (en) * 1988-09-02 1991-02-04 Amsu Ltd COMPOSITION FOR TREATMENT OF ERECT DYSFUNCTION THROUGH URETRA
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
CA2352552C (en) * 1990-04-25 2008-12-02 Virgil A. Place Treatment of erectile dysfunction
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment

Also Published As

Publication number Publication date
WO1999030718A3 (en) 1999-09-10
EP1059926A2 (en) 2000-12-20
CN1282249A (en) 2001-01-31
WO1999030718A2 (en) 1999-06-24
CA2314369A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
HRP980222B1 (en) Pyrazolopyrimidinones for the treatment of sexual disfunction
EP1027057A4 (en) Treatment of female sexual dysfunction
AU9035498A (en) Method for treating pain
IL131484A0 (en) Treatment of cardiomyopathy
AP9801414A0 (en) Combination effective for the treatment of impotence
AU2562797A (en) Combination therapy for treatment of erectile dysfunction
IL133822A0 (en) Aroylpiperazines for modulating sexual activity
EP1077704A4 (en) Combination therapy for treatment of depression
AU1827299A (en) Prostaglandin e2/f2alpha combination for treating impotence and enhancing sexual arousal
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
AUPP010397A0 (en) Method and composition for treatment of sexual dysfunction
GB9725114D0 (en) Treatment of pruritus
AU9583498A (en) Method for treating sexual dysfunction
AU9034798A (en) Method for treating pain
GB2331706B (en) Acupressure muscle relaxer tool
TW402025U (en) Vehicle muffler
ZA989394B (en) Selective functionalization of sodium glycinate
GB9712251D0 (en) Personal mobility vehicle
TW366805U (en) Massager
GB9716449D0 (en) Sexual aid
AU6623598A (en) Sexual stimulation underwear
GB9706789D0 (en) Method of and means for enhancing the enjoyment of sexual intercourse
AU8779298A (en) Limb massager
GB9721978D0 (en) Treatment of depression
AU7021694A (en) Secure enhancing condom

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase